Now online at AIDS Treatment News:

***New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting.
Interview with Stephen Becker, M.D.
KP-1461, an experimental HIV drug already in a phase II trial,
works so differently from other antiretrovirals that at first glance
it looked like science fiction, and we found it hard to take
seriously as a current possibility today. In fact this drug is highly
credible, and based on elegant science that goes back at least 25
years. KP-1461 is the only antiretroviral in human use or testing
that can eradicate HIV from laboratory cell cultures. No one knows
how it will work in people -- but we might know by the second quarter
of 2008, when the current phase II trial could be complete. AIDS
Treatment News interviewed Dr. Stephen Becker, a leading AIDS
physician and researcher who is now vice president of clinical
development at Koronis Pharmaceuticals, in Seattle, Washington.
Full article: http://www.aidsnews.org/2007/09/kp-1461.html

We sent this alert separately, because of its potential importance.

--
John S James
AIDS Treatment News
www.aidsnews.org/now (for Daily Alerts)
www.aidsnews.org